Abrilada (adalimumab-afzb) is used to treat rheumatoid,
psoriatic and juvenille idiopathic
arthritis,
ankylosing spondylitis,
hidradenitis suppurativa,
uveitis,
Crohn's disease,
plaque psoriasis and
ulcerative colitis. Abrilada is a biosimilar for
humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Abrilada is a
TNF blocker which works by reducing inflammation throughout the body. The most common form of Abrilada is a carton of two 40mg/0.8mg syringes. It is also available as a vial. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.